166 related articles for article (PubMed ID: 16519253)
1. Systemic fungal infections in renal diseases.
Gandhi BV; Bahadur MM; Dodeja H; Aggrwal V; Thamba A; Mali M
J Postgrad Med; 2005; 51 Suppl 1():S30-6. PubMed ID: 16519253
[TBL] [Abstract][Full Text] [Related]
2. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
3. Newer treatments for fungal infections.
Knapp KM; Flynn PM
J Support Oncol; 2005; 3(4):290-8. PubMed ID: 16092600
[TBL] [Abstract][Full Text] [Related]
4. Antifungal treatment strategies in high risk patients.
Rüping MJ; Vehreschild JJ; Cornely OA
Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
6. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
Moudgal VV; Sobel JD
Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
[TBL] [Abstract][Full Text] [Related]
7. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
8. Antifungal prophylaxis for invasive mycoses in high risk patients.
Ullmann AJ; Cornely OA
Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
11. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
12. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic infections in renal allograft recipients.
Gupta RK
Transplant Proc; 2007 Apr; 39(3):731-3. PubMed ID: 17445584
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infection in renal transplant recipients demonstrated by panfungal polymerase chain reaction.
Badiee P; Kordbacheh P; Alborzi A; Malekhoseini SA
Exp Clin Transplant; 2007 Jun; 5(1):624-9. PubMed ID: 17617057
[TBL] [Abstract][Full Text] [Related]
15. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
Strasfeld L; Weinstock DM
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
17. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
18. Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data.
Muñoz P; Guinea J; Narbona MT; Bouza E
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S125-31. PubMed ID: 19013336
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of fungal infection in immunocompromised patients.
Barnes RA
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i3-6. PubMed ID: 18063601
[TBL] [Abstract][Full Text] [Related]
20. [Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections].
Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Monchecourt F; Mahi L; Deray G
Med Mal Infect; 2008 Apr; 38(4):208-14. PubMed ID: 18191521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]